Trial Profile
A comparison trial assessing stent fracture between xience everolimus-and nobori biolimus-eluting stents.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Feb 2016
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Umirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- 26 Feb 2016 New trial record